Complement Dependent Cytotoxicity (CDC) Assay

In 1964, Paul Terasaki and John McClelland (Nature 204:998, 1964) introduced the microlymphocytotoxicity test, known as complement dependent cytotoxicity assay or simply CDC, which became the standard serological assay for HLA typing and cross-matching in clinical tissue transplantation.

• A Comparative Analysis of Oral Contraceptives and Levonorgestrel IUDs
• Development of mRNA Rabies Vaccines: A Promising Future
• Rabies Control in High-Burden Countries: Universal Pre-Exposure Immunization
• Tracking the Lethal Threat An In-Depth Review of Rabies
• Acromegaly, Gynaecological Health, and Complementary Therapies: A Multidisciplinary Perspective
• Prenatal Diagnosis of Ocular Malformations: Cryptophthalmos, Aphakia, and Corneal Vascularization
• Diabetic Retinopathy and Toxoplasma gondii in Pregnant Hispanic Women
• Link Between PCOS and Idiopathic Intracranial Hypertension